2017-01-27
Added · Updated
The regulator issued this circular on January 27, 2017, to provide guidance on the Phase 2 reporting requirements for OTC derivative transactions. The document serves as an enclosure containing a letter regarding training and testing protocols for market participants. It references related regulatory instruments concerning the migration to the new reporting regime and interim reporting requirements established in previous years.
CIR
Current
Issue Date:
27 Jan 2017
20170427-3-EN.pdf (1.9 MB)
Topic:
OTC Derivatives - Reporting
Group:
Specific
Directly related Document
Cross referenced Document
Version History
Superseded Document
Directly related Document
CIR
Current
27 Apr 2017
OTC Derivative Transactions – Phase 2 Reporting
CIR
Current
27 Apr 2017
OTC Derivative Transactions – Phase 2 Reporting
Cross referenced Document
Version History
Superseded Document
You may also be interested in
CIR
Archive
11 Jun 2015
Interim reporting requirements for OTC derivative transactions – migration to new reporting regime
CIR
Current
07 Sep 2015
Reporting of OTC derivative transactions
CIR
Archive
28 Jun 2013
Interim reporting requirements for OTC derivative transactions